Saiwebs Business & Economy AstraZeneca gets regulator’s nod to market cancer drug in India

AstraZeneca gets regulator’s nod to market cancer drug in India

Trastuzumab Deruxtecan is already approved in India for the treatment of metastatic breast cancer and locally advanced or metastatic gastric cancer

Related Post

Saiwebs